Clinical Trial Update: SEMEiotic Oriented Technology for Individual's CardiOmetabolic Risk Self- assessmeNt and Self-monitoring [NA]

View source ↗

Summary

Completed clinical trial evaluating SEMEiotic oriented technology for self-assessment and self-monitoring of cardiometabolic risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Syndrome

Snippet

Sponsor: Istituto di Fisiologia Clinica CNR | Conditions: Cardiovascular Risk Factor | NA | Status: COMPLETED